Abstract
The prediction of high-affinity and/or high-specificity protein–glycosaminoglycan (GAG) interactions is an inherently difficult task, due to several factors including the shallow nature of the typical GAG-binding site and the inherent size, flexibility, diversity, and polydisperse nature of the GAG molecules. Here, we present a generally applicable methodology termed Combinatorial Library Virtual Screening (CVLS) that can identify potential high-affinity, high-specificity protein–GAG interactions from very large GAG combinatorial libraries and a suitable GAG-binding protein. We describe the CVLS approach along with the rationale behind it and provide validation for the method using the well-known antithrombin–thrombin–heparin system.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Esko JD, Kimata K, Lindahl U (2009) Proteoglycans and sulfated glycosaminoglycans. In: Varki A, Cummings RD, Esko JD et al (eds) Essentials of glycobiology. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, pp 229–248
Blow N (2009) A spoonful of sugar. Nature 457:617–620
Dementiev A, Petitou M, Herbert J-M, Gettins PGW (2004) The ternary complex of antithrombin–anhydrothrombin–heparin reveals the basis of inhibitor selectivity. Nat Struct Mol Biol 11:863–867
Olson ST, Björk I (1991) Predominant contribution of surface approximation to the mechanism of heparin acceleration of the antithrombin–thrombin reaction. Elucidation from salt concentration effects. J Biol Chem 266:6353–6364
Cardin AD, Weintraub HJR (1989) Molecular modeling of protein-glycosaminoglycan interactions. Arterioscler Thromb Vasc Biol 9:21–32
Hileman RE, Fromm JR, Weiler JM, Linhardt RJ (1998) Glycosaminoglycan–protein interactions: definition of consensus sites in glycosaminoglycan binding proteins. Bioessays 20:156–167
Margalit H, Fischer N, Ben-Sasson SA (1993) Comparative analysis of structurally defined heparin binding sequences reveals a distinct spatial distribution of basic residues. J Biol Chem 268:19228–19231
Sobel M, Soler DF, Kermonde JC, Harris RB (1992) Localization and characterization of a heparin binding domain peptide of human von Willebrand factor. J Biol Chem 267:8857–8862
Bitomsky W, Wade RC (1999) Docking of glycosaminoglycans to heparin-binding proteins: validation for aFGF, bFGF, and antithrombin and application to IL-8. J Am Chem Soc 121:3004–3013
Gandhi NS, Coombe DR, Mancera RL (2008) Platelet endothelial cell adhesion molecule 1 (PECAM-1) and its interactions with glycosaminoglycans: 1. Molecular modeling studies. Biochemistry 47:4851–4862
Krieger E, Geretti E, Brandner B, Goger B, Wells TN, Kungl AJ (2004) A structural and dynamic model for the interaction of interleukin-8 and glycosaminoglycans: support from isothermal fluorescence titrations. Proteins 54:768–775
Raghuraman A, Mosier PD, Desai UR (2006) Finding a needle in a haystack: development of a combinatorial virtual screening approach for identifying high specificity heparin/heparan sulfate sequence(s). J Med Chem 49:3553–3562
Raghuraman A, Mosier PD, Desai UR (2010) Understanding dermatan sulfate–heparin co-factor II interaction through virtual library screening. ACS Med Chem Lett 1:281–285
Rogers CJ, Clark PM, Tully SE, Abrol R, Garcia C, Goddard WA III, Hsieh-Wilson LC (2011) Elucidating glycosaminoglycan–protein–protein interactions using carbohydrate microarray and computational approaches. Proc Natl Acad Sci U S A 108:9747–9752
Cole JC, Nissink JWM, Taylor R (2005) Protein–ligand docking and virtual screening with GOLD. In: Alvarez J, Shoichet B (eds) Virtual screening in drug discovery. Taylor & Francis, Boca Raton, FL, pp 379–416
Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, Olson AJ (2009) AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem 16:2785–2791
Dominguez C, Boelens R, Bonvin AMMJ (2003) HADDOCK: a protein–protein docking approach based on biochemical or biophysical information. J Am Chem Soc 125:1731–1737
Sapay N, Nurisso A, Imberty A (2013) Simulation of carbohydrates, from molecular docking to dynamics in water. Methods Mol Biol 924:469–483
Kirschner KN, Yongye AB, Tschampel SM, González-Outeiriño J, Daniels CR, Foley BL, Woods RJ (2008) GLYCAM06: a generalizable biomolecular force field. Carbohydrates. J Comput Chem 29:622–655
Woods RJ, Dwek RA, Edge CE (1995) Molecular mechanical and molecular dynamical simulations of glycoproteins and oligosaccharides. 1. GLYCAM_93 parameter development. J Phys Chem 99:3832–3846
Guvench O, Hatcher E, Venable RM, Pastor RW, MacKerell AD Jr (2009) CHARMM additive all-atom force field for glycosidic linkages between hexopyranoses. J Chem Theory Comput 5:2353–2370
Huige CJM, Altona C (1995) Force field parameters for sulfates and sulfamates based on ab initio calculations: extensions of AMBER and CHARMm fields. J Comput Chem 16:56–79
Mallajosyula SS, Guvench O, Hatcher E, MacKerell AD Jr (2012) CHARMM additive all-atom force field for phosphate and sulfate linked to carbohydrates. J Chem Theory Comput 8:759–776
Scott WRP, Hünenberger PH, Tironi IG, Mark AE, Billeter SR, Fennen J, Torda AE, Huber T, Krüger P, van Gunsteren WF (1999) The GROMOS biomolecular simulation program package. J Phys Chem A 103:3596–3607
Jin L, Barran PE, Deakin JA, Lyon M, Uhrín D (2005) Conformation of glycosaminoglycans by ion mobility mass spectrometry and molecular modelling. Phys Chem Chem Phys 7:3464–3471
Mikhailov D, Linhardt RJ, Mayo KH (1997) NMR solution conformation of heparin-derived hexasaccharide. Biochem J 328:51–61
Mikhailov D, Mayo KH, Vlahov IR, Toida T, Pervin A, Linhardt RJ (1996) NMR solution conformation of heparin-derived tetrasaccharide. Biochem J 318:93–102
Murphy KJ, McLay N, Pye DA (2008) Structural studies of heparan sulfate hexasaccharides: new insights into iduronate conformational behavior. J Am Chem Soc 130:12435–12444
Pol-Fachin L, Becker CF, Guimarães JA, Verli H (2011) Effects of glycosylation on heparin binding and antithrombin activation by heparin. Proteins 79:2735–2745
Zhang Z, McCallum SA, Xie J, Nieto L, Corzana F, Jiménez-Barbero J, Chen M, Liu J, Linhardt RJ (2008) Solution structures of chemoenzymatically synthesized heparin and its precursors. J Am Chem Soc 130:12998–13007
Gandhi NS, Mancera RL (2009) Free energy calculations of glycosaminoglycan–protein interactions. Glycobiology 19:1103–1115
Pichert A, Samsonov SA, Theisgen S, Thomas L, Baumann L, Schiller J, Beck-Sickinger AG, Huster D, Pisabarro MT (2012) Characterization of the interaction of interleukin-8 with hyaluronan, chondroitin sulfate, dermatan sulfate, and their sulfated derivatives by spectroscopy and molecular modelling. Glycobiology 22:134–145
Gilson MK, Honig B (1988) Calculation of the total electrostatic energy of a macromolecular system: solvation energies, binding energies, and conformational analysis. Proteins 4:7–18
Honig B, Nicholls A (1995) Classical electrostatics in biology and chemistry. Science 268:1144–1149
Tsui V, Case DA (2001) Theory and applications of the generalized Born solvation model in macromolecular simulations. Biopolymers 56:275–291
Li W, Johnson DJD, Esmon CT, Huntington JA (2004) Structure of the antithrombin–thrombin–heparin ternary complex reveals the antithrombotic mechanism of heparin. Nat Struct Mol Biol 11:857–862
Jones G, Willett P, Glen RC, Leach AR, Taylor R (1997) Development and validation of a genetic algorithm for flexible docking. J Mol Biol 267:727–748
Gandhi NS, Mancera RL (2008) The structure of glycosaminoglycans and their interactions with proteins. Chem Biol Drug Des 72:455–482
Mulloy B, Forster MJ (2000) Conformation and dynamics of heparin and heparan sulfate. Glycobiology 10:1147–1156
Cremer D, Pople JA (1975) A general definition of ring puckering. J Am Chem Soc 97:1354–1358
Forster MJ, Mulloy B (1993) Molecular dynamics study of iduronate ring conformations. Biopolymers 33:575–588
Rao VSR, Qasba PK, Balaji PV, Chandrasekaran R (1998) Conformation of carbohydrates. Harwood Academic, Amsterdam
Pol-Fachin L, Verli H (2008) Depiction of the forces participating in the 2-O-sulfo-α-L-iduronic acid conformational preference in heparin sequences in aqueous solutions. Carbohydr Res 343:1435–1445
Weininger D (1988) SMILES, a chemical language and information system. 1. Introduction to methodology and encoding rules. J Chem Inform Comput Sci 28:31–36
Jin L, Abrahams JP, Skinner R, Petitou M, Pike RN, Carrell RW (1997) The anticoagulant activation of antithrombin by heparin. Proc Natl Acad Sci U S A 94:14683–14688
Johnson DJD, Li W, Adams TE, Huntington JA (2006) Antithrombin–S195A factor Xa–heparin structure reveals the allosteric mechanism of antithrombin activation. EMBO J 25:2029–2037
McCoy AJ, Pei XY, Skinner R, Abrahams J-P, Carrell RW (2003) Structure of β-antithrombin and the effect of glycosylation on antithrombin’s heparin affinity and activity. J Mol Biol 326:823–833
Esko JD, Selleck SB (2002) Order out of chaos: assembly of ligand binding sites in heparan sulfate. Annu Rev Biochem 71:435–471
Carter WJ, Cama E, Huntington JA (2005) Crystal structure of thrombin bound to heparin. J Biol Chem 280:2745–2749
Faham S, Hileman RE, Fromm JR, Linhardt RJ, Rees DC (1996) Heparin structure and interactions with basic fibroblast growth factor. Science 271:1116–1120
Stouch TR (2012) Looking forward into the next 25 years: the 25th anniversary issue of the journal of computer-aided molecular design. J Comp Aided Mol Des 26:1
Mulloy B, Forster MJ, Jones C, Davies DB (1993) N.M.R. and molecular-modelling studies of the solution conformation of heparin. Biochem J 293:849–858
Acknowledgements
This work was supported by the grants HL090586 and HL107152 from the National Institutes of Health and by Award Number S10RR027411 from the National Center for Research Resources. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center for Research Resources or the National Institutes of Health.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this protocol
Cite this protocol
Sankaranarayanan, N.V., Sarkar, A., Desai, U.R., Mosier, P.D. (2015). Designing “High-Affinity, High-Specificity” Glycosaminoglycan Sequences Through Computerized Modeling. In: Balagurunathan, K., Nakato, H., Desai, U. (eds) Glycosaminoglycans. Methods in Molecular Biology, vol 1229. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-1714-3_24
Download citation
DOI: https://doi.org/10.1007/978-1-4939-1714-3_24
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-1713-6
Online ISBN: 978-1-4939-1714-3
eBook Packages: Springer Protocols